Search

Search Constraints

You searched for: Author/Creator Yamout, Bassem

Search Results

1. 004 Pregnancy-related relapse in natalizumab, fingolimod and dimethyl fumarate-treated women with multiple sclerosis. (23rd August 2021)

3. Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registry. (February 2023)

4. Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis. Issue 4 (13th January 2019)

5. Confirmed disability progression as a marker of permanent disability in multiple sclerosis. (9th June 2022)

6. Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis. (June 2023)

7. Early predictors of disability in paediatric multiple sclerosis: evidence from a multi-national registry. Issue 12 (30th September 2022)

8. Effectiveness of alternative dose fingolimod for multiple sclerosis. Issue 2 (April 2018)

10. Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practice. (December 2021)